Natalizumab May Improve Cognition and Mood in Multiple Sclerosis

Publisher： Karger

E-ISSN： 1421-9913|67|3|162-166

ISSN： 0014-3022

Source： European Neurology, Vol.67, Iss.3, 2012-01, pp. : 162-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Natalizumab in Patients with Active Relapsing-Remitting Multiple Sclerosis in Kuwait

By  

Medical Principles and Practice, Vol. 22, Iss. 5, 2013-06 ,pp. : 495-499

Karger

Access to resources Recommend Favorite

Dual-Task Assessment in Natalizumab-Treated Multiple Sclerosis Patients

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 247-251

Karger

Access to resources Recommend Favorite

Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis

By  

European Neurology, Vol. 73, Iss. 3-4, 2015-0 ,pp. : 220-229

Karger

Access to resources Recommend Favorite

Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland

By  

European Neurology, Vol. 63, Iss. 2, 2010-01 ,pp. : 101-106

Karger

Access to resources Recommend Favorite

Multiple Sclerosis-Associated Fatigue during Disease-Modifying Treatment with Natalizumab, Interferon-Beta and Glatiramer Acetate

By  

European Neurology, Vol. 65, Iss. 4, 2011-03 ,pp. : 231-232

Karger

Access to resources Recommend Favorite